StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SABOOSOD.BO$12.52-0.71%
Fair $12.52+0.0%

SABOOSOD.BO

Saboo Sodium Chloro Limited

Consumer Defensive / Packaged FoodsBSE

$12.52

-0.09 (-0.71%)

Fairly Valued+0.0%Fair Value $12.52Fund rank 23/100 · Data gapFallback financials|
SA 26/D
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 17%

FCF escenarios

weak_data · normalized FCF $-35.9M · quality 39.7/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 6/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

26/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 0.7%, below the 5% threshold
Thesis & Journal · SABOOSOD.BOLocal privado en este navegador · Saboo Sodium Chloro Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$525M

P/E

N/A

•

EV/EBITDA

17.1x

↑

ROE

0.7%

↓

Gross Margin

35.4%

↑

Debt/Equity

0.47

↑
52-Week Range$13
$10$20

TradingView lightweight chart

SABOOSOD.BO price, volumen y niveles de valoración

Último $12.52Periodo -51.1%
Fair value: $12.52

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-11.5%

FCF CAGR

—

FCF margin

-24.5%

FCF / Net income

-42.88x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $550.2M · net income $3.1M · FCF $-134.9M

2022-FY → 2025-FY

Gross margin

35.4%+8.1% pts

Operating margin

4.4%+1.3% pts

Net margin

0.6%+0.5% pts

FCF margin

-24.5%-26.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$550.2M$550.2M$517.9M$493.6M$792.8M
Net Income$3.1M$3.1M$2.3M$865000.00$236000.00
EBITDA$43.5M$43.5M$49.2M$39.2M$39.6M
EPS———0.020.01
Gross Margin35.4%35.4%34.7%38.1%27.3%
Operating Margin4.4%4.4%2.2%4.4%3.1%
Net Margin0.6%0.6%0.4%0.2%0.0%
Balance Sheet
Debt/Equity0.470.470.380.370.83
Current Ratio13.9113.91———
Cash Flow
Free Cash Flow$-134.9M$-134.9M$46.0M$-35.9M$12.3M
Returns
ROE0.7%0.7%0.5%0.2%0.1%
Valuation
EV/EBITDA17.0917.09———
P/B1.121.12———
Growth & Yield
Revenue Growth6.2%6.2%4.9%-37.7%—
EPS Growth———176.4%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -34.1%

Total return

-34.1%

Start / end P/E

n/dx → n/dx

EPS bridge

n/d → n/d

Residual

-34.1%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-34.1%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.